Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab informa… Read more
Market Cap & Net Worth: Rapid Micro Biosystems Inc (RPID)
Rapid Micro Biosystems Inc (NASDAQ:RPID) has a market capitalization of $116.28 Million ($116.28 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20726 globally and #7494 in its home market, demonstrating a -30.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rapid Micro Biosystems Inc's stock price $2.92 by its total outstanding shares 39823026 (39.82 Million).
Rapid Micro Biosystems Inc Market Cap History: 2021 to 2026
Rapid Micro Biosystems Inc's market capitalization history from 2021 to 2026. Data shows change from $423.72 Million to $116.28 Million (-34.70% CAGR).
Index Memberships
Rapid Micro Biosystems Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #568 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1873 of 3165 |
Weight: Rapid Micro Biosystems Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Rapid Micro Biosystems Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rapid Micro Biosystems Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.28x
Rapid Micro Biosystems Inc's market cap is 1.28 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $423.72 Million | $23.23 Million | -$73.52 Million | 18.24x | N/A |
| 2022 | $45.00 Million | $17.13 Million | -$60.81 Million | 2.63x | N/A |
| 2023 | $29.47 Million | $22.52 Million | -$52.47 Million | 1.31x | N/A |
| 2024 | $35.84 Million | $28.05 Million | -$46.89 Million | 1.28x | N/A |
Competitor Companies of RPID by Market Capitalization
Companies near Rapid Micro Biosystems Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Rapid Micro Biosystems Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Rapid Micro Biosystems Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Rapid Micro Biosystems Inc's market cap moved from $423.72 Million to $ 116.28 Million, with a yearly change of -34.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $116.28 Million | +0.69% |
| 2025 | $115.49 Million | +222.22% |
| 2024 | $35.84 Million | +21.62% |
| 2023 | $29.47 Million | -34.51% |
| 2022 | $45.00 Million | -89.38% |
| 2021 | $423.72 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Rapid Micro Biosystems Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $116.28 Million USD |
| MoneyControl | $116.28 Million USD |
| MarketWatch | $116.28 Million USD |
| marketcap.company | $116.28 Million USD |
| Reuters | $116.28 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.